Some manufacturers are now embedding CER processes within broader regulatory operating systems, integrating authoring, surveillance, and quality management to enable real-time adaptability. Artificial Intelligence (AI) , in particular, is playing an increasingly critical role in helping manufacturers meet expanding regulatory expectations.
A comprehensive update on the combination products market shows significant industry partnerships, development challenges, and strategic imperatives for success in the sector characterized by dynamic collaboration between pharmaceutical and device companies, rapid product development cycles, and complex regulatory landscapes.
Shift Left, an approach to revenue cycle, may help clinics reimagine billing – not as a back-end cleanup job, but as something solved upstream at registration, like eligibility checks and authorizations – before a single claim is ever submitted. Are fewer denials, faster payments, and stronger financial footing possible for clinics already stretched thin?
Understanding the nuances is crucial in determining the regulatory submission pathway, data requirements, and even post-approval compliance expectations.
The future of healthcare depends on cross-sector collaboration among regulatory, commercial, R&D, and business development teams. This integrated approach is crucial to avoiding siloed decisions that could hinder long-term progress. Sustainability must be embedded throughout the product life cycle—from design and manufacturing to distribution and use—ensuring products not only restore sight but also address pressing environmental and logistical challenges.
When hardware and firmware are developed by separate vendors, diagnosing issues like symptoms of non-performance becomes slower and more complex. Unified engineering teams are essential to MedTech success.
Increasing patient demand, barriers to access, and elevated costs are pushing healthcare providers to reconsider traditional clinical and operational workflows to meet growing challenges and improve patient outcomes. Artificial intelligence (AI), robotics, and digital therapeutic solutions are streamlining processes and expanding the possibilities for reimagining care delivery. As these technologies converge, the shift from complex high-cost interventions toward lighter more adaptive care models creates opportunity to better meet the needs of diverse patient populations.
The human kidney is a masterclass in biological engineering. Responsible for filtering approximately 50 gallons of blood daily, this vital organ performs more than waste removal. Through processes like selective reabsorption, it carefully maintains balance in the body, regulating essential nutrients, water, and electrolytes. This unparalleled functionality cannot be replicated by available technology.
FHIR (Fast Healthcare Interoperability Resources) is an open standard designed to streamline data sharing within national healthcare systems and across systems in different countries. Its introduction aims to bring more consistency to patient care, ensuring that no matter where healthcare professionals (HCPs) are located, they can access the same up-to-date information on medications and their patients.
How does combining AI with Lean Management significantly improve efficiency in MedTech engineering? Much like IDEs or CAD tools before it, AI is becoming an essential enabler in reducing friction throughout the product development lifecycle—from onboarding and requirements generation to coding and testing—ultimately enhancing both productivity and innovation. Identifying and targeting inefficiencies using Lean principles, MedTech engineering organizations can unlock AI’s full potential to accelerate development and deliver higher-quality healthcare technologies.